Keyphrases
Systematic Meta-analysis
100%
Atorvastatin
100%
Meta-analysis of Randomized Controlled Trials
100%
Preeclampsia Prevention
100%
Preeclampsia
66%
Pregnant Women
33%
Statistical Analysis
22%
Perinatal Outcome
22%
Risk Reduction
11%
Inclusion Criteria
11%
Maternal Morbidity
11%
Maternal Mortality
11%
Randomized Controlled Trial
11%
CINAHL
11%
ScienceDirect
11%
Scopus
11%
PubMed
11%
Review Manager
11%
EBSCO
11%
Birth Weight
11%
Literature Search
11%
Neonatal Morbidity
11%
Length of Stay
11%
Maternal-neonatal
11%
Preterm Delivery
11%
Large Sample Size
11%
Neonatal Outcome
11%
Premature Birth
11%
Small-for-gestational Age
11%
Respiratory Distress Syndrome
11%
NICU Admission
11%
Apgar Score
11%
Healthy Pregnant Women
11%
Preeclampsia with Severe Features
11%
Treatment Study
11%
Medicine and Dentistry
Randomized Controlled Trial
100%
Meta-Analysis
100%
Systematic Review
100%
Pre-Eclampsia
100%
Pravastatin
100%
Maternal Mortality
9%
Maternal Morbidity
9%
Premature Labor
9%
Apgar Score
9%
Birth Weight
9%
Prematurity
9%
Perinatal Morbidity
9%
Neonatal Intensive Care Unit
9%
Small for Gestational Age
9%
Hyaline Membrane Disease
9%
Offspring
9%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Preeclampsia
100%
Pravastatin
100%
Maternal Morbidity
9%
Maternal Mortality
9%
Premature Labor
9%
Prematurity
9%
Perinatal Morbidity
9%
Small for Date Infant
9%
Hyaline Membrane Disease
9%